Close

Immunogen, Inc. (IMGN) Posts Q1 Loss of $0.26, Sales Fall Short

October 27, 2011 4:30 PM EDT
Immunogen, Inc. (NASDAQ: IMGN) reported Q1 EPS of ($0.26), $0.04 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $5.61 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings